表紙
市場調查報告書

人工水晶體 (IOL) - 醫療設備的開發平台評估

Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 920913
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
Back to Top
人工水晶體 (IOL) - 醫療設備的開發平台評估 Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月16日內容資訊: 英文 216 Pages
簡介

本報告提供目前開發中的人工水晶體 (IOL)的開發中產品資訊調查分析,提供主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 人工水晶體 (IOL)的概要

第3章 開發中的產品

  • 人工水晶體 (IOL) - 開發中產品:各開發階段
  • 人工水晶體 (IOL) - 開發中產品:各市場區隔
  • 人工水晶體 (IOL) - 開發中產品:各地區
  • 人工水晶體 (IOL) - 開發中產品:各法規途徑
  • 人工水晶體 (IOL) - 開發中產品:各核准時期 (預定)
  • 人工水晶體 (IOL) - 進行中的臨床實驗

第4章 人工水晶體 (IOL) :正在開發的開發中產品 (各企業)

  • 人工水晶體 (IOL) 企業 - 開發中產品:各開發階段
  • 人工水晶體 (IOL) - 開發中產品:各開發階段

第5章 人工水晶體 (IOL) 企業與產品概要

  • Abbott Medical Optics Inc
  • AcuFocus Inc
  • Adoptics AG (暫停中)
  • AkkoLens International BV
  • Alcon Inc
  • Anew Optics, Inc.
  • Bausch & Lomb Inc
  • Care Group
  • Clarvista Medical Inc
  • ClearSight LLC
  • Elenza, Inc.
  • Emmetrope Incorporated
  • EyeKon Medical Inc
  • Hoya Surgical Optics Inc
  • InnFocus Inc
  • Innovia LLC
  • Johnson & Johnson Vision Care Inc
  • LayerBio Inc
  • LensGen, Inc.
  • Lenstec Inc
  • London Eye Hospital
  • Medicontur Medical Engineering Ltd
  • Meir Medical Center
  • Morcher Gmbh
  • Nayam Innovations Pvt Ltd
  • Nidek Co Ltd
  • Northwestern University
  • NuLens Ltd. (暫停中)
  • Ocumetics Technology Corp
  • Omega Ophthalmics LLC
  • PhysIOL SA
  • Presbeasy
  • Rayner Intraocular Lenses Ltd
  • Sav-Iol SA
  • STAAR Surgical Company
  • Strathspey Crown LLC
  • University of East Anglia
  • University of Rochester
  • University of Tampere
  • Visidome Ltd
  • Visioneering Technologies Inc
  • VisusNano Labs
  • VSY Biotechnology BV
  • Washington University in St Louis
  • Xend
  • Z Lens LLC

第6章 人工水晶體 (IOL) :最近的趨勢

第7章 附錄

目錄
Product Code: GDME0856EPD

GlobalData's Medical Devices sector report, "Intraocular Lens (IOL) - Medical Devices Pipeline Assessment, 2019" provides an overview of Intraocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intraocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Intraocular Lens (IOL) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intraocular Lens (IOL) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intraocular Lens (IOL) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 7
  • 1.2 List of Figures 12

2 Introduction 13

  • 2.1 Intraocular Lens (IOL) Overview 13

3 Products under Development 14

  • 3.1 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 14
  • 3.2 Intraocular Lens (IOL) - Pipeline Products by Segment 15
  • 3.3 Intraocular Lens (IOL) - Pipeline Products by Territory 16
  • 3.4 Intraocular Lens (IOL) - Pipeline Products by Regulatory Path 17
  • 3.5 Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date 18
  • 3.6 Intraocular Lens (IOL) - Ongoing Clinical Trials 19

4 Intraocular Lens (IOL) - Pipeline Products under Development by Companies 20

  • 4.1 Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development 20
  • 4.2 Intraocular Lens (IOL) - Pipeline Products by Stage of Development 22

5 Intraocular Lens (IOL) Companies and Product Overview 25

  • 5.1 Abbott Medical Optics Inc Company Overview 25
    • 5.1.1 Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.2 AcuFocus Inc Company Overview 27
    • 5.2.1 AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.3 Adoptics AG (Inactive) Company Overview 31
    • 5.3.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.4 AkkoLens International BV Company Overview 32
    • 5.4.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.5 Alcon Inc Company Overview 33
    • 5.5.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.6 Anew Optics, Inc. Company Overview 38
    • 5.6.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 Bausch & Lomb Inc Company Overview 39
    • 5.7.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.8 Care Group Company Overview 43
    • 5.8.1 Care Group Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.9 Clarvista Medical Inc Company Overview 50
    • 5.9.1 Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.10 ClearSight LLC Company Overview 54
    • 5.10.1 ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.11 Elenza, Inc. Company Overview 55
    • 5.11.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.12 Emmetrope Incorporated Company Overview 56
    • 5.12.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.13 EyeKon Medical Inc Company Overview 59
    • 5.13.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.14 Hoya Surgical Optics Inc Company Overview 60
    • 5.14.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.15 InnFocus Inc Company Overview 61
    • 5.15.1 InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.16 Innovia LLC Company Overview 62
    • 5.16.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.17 Johnson & Johnson Vision Care Inc Company Overview 63
    • 5.17.1 Johnson & Johnson Vision Care Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.18 LayerBio Inc Company Overview 66
    • 5.18.1 LayerBio Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.19 LensGen, Inc. Company Overview 67
    • 5.19.1 LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.20 Lenstec Inc Company Overview 68
    • 5.20.1 Lenstec Inc Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.21 London Eye Hospital Company Overview 71
    • 5.21.1 London Eye Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.22 Medicontur Medical Engineering Ltd Company Overview 72
    • 5.22.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.23 Meir Medical Center Company Overview 74
    • 5.23.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.24 Morcher Gmbh Company Overview 75
    • 5.24.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.25 Nayam Innovations Pvt Ltd Company Overview 88
    • 5.25.1 Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.26 Nidek Co Ltd Company Overview 90
    • 5.26.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90
  • 5.27 Northwestern University Company Overview 92
    • 5.27.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 92
  • 5.28 NuLens Ltd. (Inactive) Company Overview 93
    • 5.28.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93
  • 5.29 Ocumetics Technology Corp Company Overview 94
    • 5.29.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 94
  • 5.30 Omega Ophthalmics LLC Company Overview 95
    • 5.30.1 Omega Ophthalmics LLC Pipeline Products & Ongoing Clinical Trials Overview 95
  • 5.31 PhysIOL SA Company Overview 98
    • 5.31.1 PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview 98
  • 5.32 Presbeasy Company Overview 99
    • 5.32.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview 99
  • 5.33 Rayner Intraocular Lenses Ltd Company Overview 100
    • 5.33.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.34 Sav-Iol SA Company Overview 101
    • 5.34.1 Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.35 STAAR Surgical Company Company Overview 102
    • 5.35.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 102
  • 5.36 Strathspey Crown LLC Company Overview 113
    • 5.36.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview 113
  • 5.37 University of East Anglia Company Overview 114
    • 5.37.1 University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview 114
  • 5.38 University of Rochester Company Overview 115
    • 5.38.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 115
  • 5.39 University of Tampere Company Overview 116
    • 5.39.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 116
  • 5.40 Visidome Ltd Company Overview 117
    • 5.40.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview 117
  • 5.41 Visioneering Technologies Inc Company Overview 118
    • 5.41.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 118
  • 5.42 VisusNano Labs Company Overview 119
    • 5.42.1 VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview 119
  • 5.43 VSY Biotechnology BV Company Overview 120
    • 5.43.1 VSY Biotechnology BV Pipeline Products & Ongoing Clinical Trials Overview 120
  • 5.44 Washington University in St Louis Company Overview 121
    • 5.44.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 121
  • 5.45 Xend Company Overview 122
    • 5.45.1 Xend Pipeline Products & Ongoing Clinical Trials Overview 122
  • 5.46 Z Lens LLC Company Overview 123
    • 5.46.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview 123

6 Intraocular Lens (IOL)- Recent Developments 124

  • 6.1 Nov 21, 2019: Edmund Optics features new products, including TECHSPEC Laser Focusing Singlet Lenses and TECHSPEC Off-Axis Ellipsoidal Mirrors 124
  • 6.2 Nov 19, 2019: Alcon reports third quarter and nine months 2019 results 124
  • 6.3 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 126
  • 6.4 Nov 04, 2019: Bausch Health Companies announces third-quarter 2019 results and raises full-year revenue and adjusted EBITDA (non-GAAP) guidance ranges 127
  • 6.5 Oct 31, 2019: Johnson & Johnson Vision launches TECNIS Eyhance Monofocal Intraocular Lens in India 128

7 Appendix 213

  • 7.1 Methodology 213
  • 7.2 About GlobalData 216
  • 7.3 Contact Us 216
  • 7.4 Disclaimer 216

List of Tables

  • Table 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Table 2: Intraocular Lens (IOL) - Pipeline Products by Segment
  • Table 3: Intraocular Lens (IOL) - Pipeline Products by Territory
  • Table 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Table 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Table 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
  • Table 7: Intraocular Lens (IOL) Companies - Pipeline Products by Stage of Development
  • Table 8: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Table 9: Abbott Medical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Intraocular Lens - Astigmatism - Product Status
  • Table 11: Intraocular Lens - Astigmatism - Product Description
  • Table 12: Intraocular Lens - Presbyopia - Product Status
  • Table 13: Intraocular Lens - Presbyopia - Product Description
  • Table 14: AcuFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: IC-8 IOL - Product Status
  • Table 16: IC-8 IOL - Product Description
  • Table 17: AcuFocus Inc - Ongoing Clinical Trials Overview
  • Table 18: IC-8 IOL - A Prospective Study of Small Aperture Intraocular Lens (IOL) Implantation in KAMRA Inlay Patients After Inlay Removal
  • Table 19: IC-8 IOL - Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
  • Table 20: IC-8 IOL - Evaluation of Long-term Clinical Acceptability and Satisfaction with the IC-8 Intraocular Lens
  • Table 21: IC-8 IOL - Interindividual Comparison Trial - Two Intraocular Lenses with Extended Depth of Focus
  • Table 22: Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Shape-Changing Accommodating Intraocular Lens - Product Status
  • Table 24: Shape-Changing Accommodating Intraocular Lens - Product Description
  • Table 25: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: AkkoLens IOL - Product Status
  • Table 27: AkkoLens IOL - Product Description
  • Table 28: Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status
  • Table 30: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description
  • Table 31: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status
  • Table 32: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description
  • Table 33: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status
  • Table 34: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description
  • Table 35: AcrySof IQ Toric Diopter Range Expansion - Product Status
  • Table 36: AcrySof IQ Toric Diopter Range Expansion - Product Description
  • Table 37: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status
  • Table 38: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description
  • Table 39: FluidVision Lens - Product Status
  • Table 40: FluidVision Lens - Product Description
  • Table 41: Intrepid IOL - Product Status
  • Table 42: Intrepid IOL - Product Description
  • Table 43: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Zephyr Lens - Product Status
  • Table 45: Zephyr Lens - Product Description
  • Table 46: Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: enVista MX60EF Trifocal IOL - Product Status
  • Table 48: enVista MX60EF Trifocal IOL - Product Description
  • Table 49: Sarfarazi Elliptical Accommodating IOL - Product Status
  • Table 50: Sarfarazi Elliptical Accommodating IOL - Product Description
  • Table 51: Bausch & Lomb Inc - Ongoing Clinical Trials Overview
  • Table 52: enVista MX60EF Trifocal IOL - A Prospective, Multicenter, Randomized, Active-controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction
  • Table 53: Care Group Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Aniridia IOL - Product Status
  • Table 55: Aniridia IOL - Product Description
  • Table 56: Diffractive Hydrophilic IOL (MICL) - Product Status
  • Table 57: Diffractive Hydrophilic IOL (MICL) - Product Description
  • Table 58: Hydrophilic Diffractive IOL - Product Status
  • Table 59: Hydrophilic Diffractive IOL - Product Description
  • Table 60: Hydrophobic Diffractive IOL (MICL) - Product Status
  • Table 61: Hydrophobic Diffractive IOL (MICL) - Product Description
  • Table 62: Hydrophobic IOL (MICL) - Product Status
  • Table 63: Hydrophobic IOL (MICL) - Product Description
  • Table 64: IPCL Monofocal - Product Status
  • Table 65: IPCL Monofocal - Product Description

List of Figures

  • Figure 1: Intraocular Lens (IOL) - Pipeline Products by Stage of Development
  • Figure 2: Intraocular Lens (IOL) - Pipeline Products by Segment
  • Figure 3: Intraocular Lens (IOL) - Pipeline Products by Territory
  • Figure 4: Intraocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Figure 5: Intraocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Figure 6: Intraocular Lens (IOL) - Ongoing Clinical Trials
Back to Top